Mathias Ellgaard Cook

Medicine and Dentistry

1. 17 Methylnaltrexone 33%
2. Acute Pancreatitis 100%
3. Adverse Event 7%
4. Adverse Outcome 7%
5. All Cause Mortality 33%
6. Amaurosis 66%
7. Association 7%
8. Blood 7%
9. Cardiovascular Disease 33%
10. Central Nervous System 33%
11. Chronic Pancreatitis 11%
12. Clinical Trial 33%
13. Cognition 8%
14. Cohort Analysis 66%
15. Complication 9%
16. Computer Assisted Tomography 6%
17. Diabetes 6%
18. Diabetes Mellitus 33%
19. Disease Exacerbation 11%
20. Disease Severity 13%
21. Enteric Nervous System 33%
22. Gastrointestinal Distress 12%
23. Gastrointestinal Motility 8%
24. Gastrointestinal Tract 7%
25. Gastrointestinal Transit 8%
26. Glycon 33%
27. Gut 11%
28. Hazard Ratio 7%
29. Hypoglycemia 33%
30. Inpatient 47%
31. Maturity Onset Diabetes of the Young 7%
32. Memory 8%
33. Mortality 6%
34. Opiate 51%
35. Opiate Antagonist 66%
36. Pain 13%
37. Pancreas Disease 33%
38. Pancreatitis 58%
39. Patient 23%
40. Placebo 70%
41. Randomized Controlled Trial 37%
42. Recurrent Disease 7%
43. Scoring System 6%
44. Sedation 8%
45. Symptom 7%
46. Therapeutic Procedure 48%